Abstract
THE radiation-mortality reducing action of cell-free extracts obtained from spleens of mice, guinea pigs and dogs has been demonstrated in a series of previous investigations1,2. The extraction procedure used for preparing spleen extracts has been described elsewhere2,3. The observation that homologous, as well as the heterologous, spleen extracts were equally effective suggests that a common chemical entity (or entities) may be the therapeutic agent4. This is a preliminary report of the isolation and characterization of fractions obtained from dog spleen extracts which contain this factor.
Similar content being viewed by others
References
Jacobson, L. O., Cancer Res., 12, 315 (1952).
Ellinger, F., Amer. J. Roentgen., Rad. Therap. and Nuc. Med., 87, 547 (1962).
Ellinger, F., and Lindsley, B. F., Arch. Int. Pharmacodynamie et de Therapie, 132, 310 (1961).
Ellinger, F., and Strike, T. A., Acta Hœmatologica, 26, 117 (1961).
Ashikawa, J. K., and Anderson, O. K., Rad. Res., 13, 99 (1960).
Ferris, T. G., Easterling, R. G., and Budd, R. G., Blood, 19, 479 (1962).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
KATZ, S., ELLINGER, F. Isolation of a Radiation-Mortality Reducing Factor from Spleen. Nature 197, 397–399 (1963). https://doi.org/10.1038/197397b0
Issue Date:
DOI: https://doi.org/10.1038/197397b0
- Springer Nature Limited
This article is cited by
-
Effect of extracts of the spleen on the primary immune response in mice
Bulletin of Experimental Biology and Medicine (1976)
-
Zur Frage der Beziehung zwischen Milz und Knochenmark nach einer Ganzk�rperbestrahlung
Die Naturwissenschaften (1963)